期刊文献+

CpG ODN对哮喘小鼠气道炎症及GATA-3的影响 被引量:5

Effect of CpG oligodeoxynucleotides on airway inflammation and transcription factor GATA-3 mRNA expression in asthmatic mice
下载PDF
导出
摘要 目的观察CpGODN对支气管哮喘小鼠气道炎症及肺组织GATA-3mRNA表达的影响。方法将40只雌性BALB/C小鼠随机分为4组(每组10只):生理盐水对照组(A组);哮喘组(B组);CpGODN干预组(C组);GpCODN对照组(D组)。以鸡卵白蛋白(OVA)致敏小鼠建立哮喘模型,C组和D组在OVA激发前分别予CpGODN及对照GpCODN腹腔注射。在末次激发后24h收集各组小鼠的支气管肺泡灌洗液行白细胞计数及EOS分类计数,ELISA法检测各组小鼠BALF中IL-4、IL-5及IFN-γ水平,肺组织HE染色观察其病理变化以及用逆转录聚合酶链反应(RT-PCR)方法检测肺组织中GATA-3mRNA的表达。结果各组BALF中白细胞总数、嗜酸性粒细胞百分比、IL-4、IL-5和IFN-γ浓度分别为:A组为(7.46±1.77)×105个/mL、(0.75±0.48)%、(26.9±4.6)pg/mL、(41.7±5.1)pg/mL和(110.4±12.1)pg/mL,B组为(21.68±4.40)×105个/mL、(9.50±1.13)%、(267.6±24.5)pg/mL、(218.2±15.2)pg/mL和(47.9±9.6)pg/mL,C组为(8.98±2.23)×105个/mL、(2.90±0.86)%、(85.9±8.1)pg/mL、(63.0±9.6)pg/mL和(221.0±29.9)pg/mL,D组为(20.41±3.47)×105个/mL、(9.60±1.30)%、(260.7±15.7)pg/mL、(205.1±15.8)pg/mL和(52.2±10.7)pg/mL。B组与A组比较差异有显著性(P<0.01),C组与B组比较差异有显著性(P<0.01),D组与B组比较差异无显著性(P>0.05)。C组小鼠肺组织GATA-3mRNA的表达较B组明显减低,差异有显著性(P<0.01),D组与B组比较差异无显著性(P>0.05)。结论CpGODN可以抑制哮喘小鼠Th2型细胞因子生成,抑制肺部GATA-3mRNA的表达,减轻哮喘气道炎症。 [Objective] To investigate the effect of CpG oligodeoxynucleotides(CpG ODN) on airway inflammation and transcription factor GATA-3 mRNA expression in asthmatic mice.[Methods] Fourty female BALB/C mice were randomly divided into four groups(10 mice in each group): saline control group(group A); asthmatic group(group B); CpG ODN intervention group (group C); GpC ODN control group(group D). Mice were sensitized by intraperitoneally injection of OVA/alum on days 0, 7, 14, and 21, and subsequently received nebulized 2% OVA on days 25, 26, 27 and 28. Groups C and D were treated with CpG ODN or GpC ODN(50 μg/mouse) intraperitoneally 24 h before OVA inhalation challenges. All the mice were killed 24 h after the final OVA challenge, bronchoalveolar lavage fluid (BALF)were collected for counting total inflammatory cells and the percentage of eosinophils, IFN-γ, IL-4 and IL-5concentrations in BALF were detected using an enzyme-linked immunosorbent assay, transcription factor GATA-3 mRNA expression in lung tissue was detected by reverse transcription-polymerase chain reaction. [Results] The total inflammatory cells, percentage of eosinophils, concentrations of IL-4, IL-5 and IFN-γ in BALF in each group were as follows: in group A they were (7.46±1.77)×10^5/mL, (0.75±0.48)%, (26.9±4.6)pg/mL, (41.7±5.1)pg/mL, (110.4±12.1)pg/mL respectively; in group B they were (21.68±4.40)×10^5/mL, (9.50±1.13)%, (267.6±24.5)pg/mL, (218.2±15.2)pg/mL, (47.9±9.6)pg/mL respectively; in group C they were (8.98±2.23)×10^5/mL, (2.90±0.86)%, (85.9± 8.1)pg/mL, (63.0±9.6)pg/mL, (221.0±29.9)pg/mL respectively; in group D they were (20.41±3.47)×10^5/mL, (9.60±1.30)%, (260.7± 15.7)pg/mL, (205.1±15.8)pg/mL, (52.2±10.7)pg/mL respectively. Group B was significantly different from group A(P 〈0.01), group C was significantly different from group B(P 〈0.01), group D was not significantly different from group C(P 〉0.05). The GATA-3 mRNA expression was reduced in lung tissue in group C compared with group B, group C was obviously different from group B(P 〈0.01), but there was no difference between group D and group B(P 〉0.05).[Conclusions] This study suggests that CpG ODN could inhibit production of Th2 cytokines, down-regulate GATA-3 mRNA expression, and relieve the allergic inflammation of airway in asthmatic mice.
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2008年第5期563-567,共5页 China Journal of Modern Medicine
关键词 支气管哮喘 CPG ODN 细胞因子 GATA-3 asthma CpG ODN cytokines GATA-3
  • 相关文献

参考文献13

  • 1RENAULD JC. New insights into the role of cytokines in asthma [J]. J Clin Pathol, 2001, 54(8): 577-589.
  • 2KLINE JN, KITAGAKI K, BUSINGA TR, et al. Treatment of established asthma in a murine model using CpG oligodeoxynucleotides[J]. Am J Physiol Lung Cell Mol Physiol, 2002, 283: L170-L179.
  • 3KIWAMOTO T, ISHII Y, MORISHIMA Y, et al. Transcription factors T-bet and GATA-3 regulate development of airway remodeling [J]. Am J Respir Crit Care Med, 2006, 174 (2): 142-151.
  • 4YOSHIDA M, LEIGH R, MATSUMOTO K, et al. Effect of interferon-gamma on allergic airway responses in interferon-gamma-deficient mice[J]. Am J Respir Crit Care Med, 2002, 166(4): 451-456.
  • 5HAYASHI T, GONG X, ROSSETTO C, et al. Induction and inhibition of the Th2 phenotype spread: implications for childhood asthma[J]. J Immunol, 2005, 174(9): 5864-5873.
  • 6TAKABAYASHI K, LIBET L, CHISHOLM D. et al. Intranasal immunotherapy is more effective than intradermal immunotherapy for the induction of airway allergen tolerance in Th2-sensitized mice[J]. J Immunol, 2003, 170(7): 3898-3905.
  • 7BHATTACHARIEE RN, AKIRA S. Modifying toll-like receptor 9 signaling for therapeutic use[J]. Mini Rev Med Chem, 2006, 6(3): 287-291.
  • 8DAVID BROIDE, JURGAN SCHWARZE, HELEN TIGHE, et al. Immunosfimulatory DNA sequences inhibit IL-5, eosinophilic inflammation, and airway hyperresponsiveness in mice [J]. J Immunol, 1998, 161: 7054-7062.
  • 9Jinfang Zhu Hidehiro Yamane Javier Cote-Sierra Liying Guo William E Paul.GATA-3 promotes Th2 responses through three different mechanisms: induction of Th2 cytokine production, selective growth of Th2 cells and inhibition of Thl cell-specific factors[J].Cell Research,2006,16(1):3-10. 被引量:49
  • 10吴秀明,戴爱国,李继红.肾上腺髓质素及其受体在支气管哮喘发病中对增殖与凋亡的影响[J].中国现代医学杂志,2005,15(8):1271-1274. 被引量:6

二级参考文献62

  • 1Mowen KA, Glimcher LH. Signaling pathways in Th2 development. Immunol Rev 2004; 202:203-22.
  • 2Murphy KM, Reiner SL. The lineage decisions of helper T cells.Nat Rev Immunol 2002; 2:933-44.
  • 3Laouar Y, Sutterwala FS, Gorelik L, Flavell RA. Transforming growth factor-beta controls T helper type 1 cell development through regulation of natural killer cell interferon-gamma. Nat Immunol 2005; 6:600-7.
  • 4Szabo S J, Kim ST, Costa GL, et al. A novel transcription factor,T-bet, directs Th1 lineage commitment. Cell 2000; 100:655-69.
  • 5Szabo S J, Sullivan BM, Stemmann C, et al. Distinct effects of T-bet in Thl lineage commitment and IFNgamma production in CD4 and CD8 T cells. Science 2002; 295:338-42.
  • 6Lighvani AA, Frucht DM, Jankovic D, et al. T-bet is rapidly induced by interferon-gamma in lymphoid and myeloid cells.Proc Natl Acad Sci USA 2001 ; 98:15137-42.
  • 7Afkarian M, Sedy JR, Yang J, et al. T-bet is a STATl-induced regulator of IL-12R expression in naive CD4+ T cells. Nat Immunol 2002; 3:549-57.
  • 8Mullen AC, High FA, Hutchins AS, et al. Role ofT-bet in commitment of Th 1 cells before IL-12-dependent selection. Science 2001; 292:1907-10.
  • 9Nelms K, Keegan AD, Zamorano J, Ryan J J, Paul WE. The IL-4 receptor: Signaling mechanisms and biologic functions. Annu Rev Immunol 1999; 17:701-38.
  • 10Kaplan MH, Schindler U, Smiley ST, Grusby MJ. Stat6 is required for mediating responses to IL-4 and for the development of Th2 cells. Immunity 1996; 4:313-9.

共引文献53

同被引文献97

引证文献5

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部